Skip to main content
. 2011 May 10;5(5):e1044. doi: 10.1371/journal.pntd.0001044

Table 3. Outcome of treatment among the three study groups.

Parameters Albendazol(N = 30) Ivermectin-I(N = 31) Ivermectin-II(N = 29) P-value
Duration of follow up
- Median (range), weeks 19(2–76) 39(2–74) 26 (2–74) 0.248
Outcome: Parasitological responses 0.006
- Elimination, n (%) 19 (63.3) 30 (96.8) 27 (93.1)
- Failure 11 (36.7) 1 (3.2) 2 (6.9)
- Persistence at 2 week 2 0 2
- Relapse /reinfection 9 1 0